Section Arrow
LNTH.NASDAQ
- Lantheus Holdings
Quotes are at least 15-min delayed:2026/03/03 05:49 EST
Pre Market
Last
 75.23
-1.08 (-1.42%)
Bid
70.3
Ask
80.2
High 76.29 
Low 75.15 
Volume 311 
Regular Hours (Closed)
Last
 76.3
+1.38 (+1.84%)
Day High 
78.79 
Prev. Close
74.92 
1-M High
80.91 
Volume 
1.16M 
Bid
70.3
Ask
80.2
Day Low
74.24 
Open
74.58 
1-M Low
63.45 
Market Cap 
4.97B 
Currency 美元 
P/E 31.09 
%Yield -- 
10-SMA 73.39 
20-SMA 69.87 
50-SMA 68.05 
52-W High 111.29 
52-W Low 47.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.41/6.72
Enterprise Value
5.59B
Balance Sheet
Book Value Per Share
16.88
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
1.53B
Operating Revenue Per Share
18.18
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health16.48+1.96+13.50%28.59PE
Pre Market 15.71 -0.77 -4.67%
VTRSViatris15.7+0.79+5.30%-- 
Pre Market 15.5 -0.2 -1.27%
CGCCanopy Growth Corp1.07-0.06-5.31%-- 
Pre Market 1.07 -0.015 -1.38%
BHCBausch Health Companies5.95+0.02+0.34%14.12PE
Pre Market 5.92 -0.03 -0.50%
HLNHaleon plc10.87-0.2-1.81%24.58PE
Pre Market 10.51 -0.36 -3.31%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.